Category Archives: Uncategorized

This retrospective study evaluated the effectiveness of corneal cross-linking (CXL) in eyes with advanced keratoconus. Source: AAO

• Posted on: Nov 30 2018
• By: Saratoga Opthalmology
• Leave a response

Investigators prospectively compared the effects of bromfenac and indomethacin on intraoperative pupil size during cataract surgery. Source: AAO

• Posted on: Nov 29 2018
• By: Saratoga Opthalmology
• Leave a response

This longitudinal, observational study assessed the association between physical activity and rate of visual field loss in patients with glaucoma. Source: AAO

• Posted on: Nov 28 2018
• By: Saratoga Opthalmology
• Leave a response

In this study, the authors investigate the association between circulating S100A8/A9 levels and uveitis activity. Source: AAO

• Posted on: Nov 27 2018
• By: Saratoga Opthalmology
• Leave a response

Genentech has landed FDA approval for a single-dose autoinjector filled with tocilizumab (Actemra ) for patients with giant cell arteritis (GCA). Source: AAO

• Posted on: Nov 27 2018
• By: Saratoga Opthalmology
• Leave a response

The authors of this study describe a new efficient technique to separate the lenticule edge during small incision lenticule extraction (SMILE). Source: AAO

• Posted on: Nov 26 2018
• By: Saratoga Opthalmology
• Leave a response

Investigators evaluated the optimal dose of preoperative intravitreal bevacizumab in patients undergoing vitrectomy for proliferative diabetic retinopathy (PDR). Source: AAO

• Posted on: Nov 21 2018
• By: Saratoga Opthalmology
• Leave a response

This study retrospectively assessed the risk of ophthalmic vascular events following intra-arterial chemotherapy (IAC) for retinoblastoma. Source: AAO

• Posted on: Nov 20 2018
• By: Saratoga Opthalmology
• Leave a response

This case report describes 3 patients who developed an afferent pupillary defect following microsurgical clipping of an anterior communicating artery aneurysm. Source: AAO

• Posted on: Nov 19 2018
• By: Saratoga Opthalmology
• Leave a response

Investigators compared the anatomic and functional outcomes of half-dose photodynamic therapy (PDT) versus high-density subthreshold micropulse laser (HSML) in patients with chronic central serous chorioretinopathy (CSC). Source: AAO

• Posted on: Nov 16 2018
• By: Saratoga Opthalmology
• Leave a response